242 related articles for article (PubMed ID: 22490464)
1. Tumor lysis syndrome in patients with light chain multiple myeloma: report of two cases.
Chang H; Lee SY; Tang TC
Chang Gung Med J; 2011; 34(6 Suppl):70-5. PubMed ID: 22490464
[TBL] [Abstract][Full Text] [Related]
2. Management of tumor lysis syndrome in patients with multiple myeloma during bortezomib treatment.
Wang L; Jian Y; Yang G; Gao W; Wu Y; Zuo L
Clin J Oncol Nurs; 2015 Feb; 19(1):E4-7. PubMed ID: 25689664
[TBL] [Abstract][Full Text] [Related]
3. Carfilzomib-associated tumor lysis syndrome.
Shely RN; Ratliff PD
Pharmacotherapy; 2014 May; 34(5):e34-7. PubMed ID: 24390940
[TBL] [Abstract][Full Text] [Related]
4. Carfilzomib-induced tumor lysis syndrome in relapsed multiple myeloma: a report of two cases.
Terzi Demirsoy E; Birtas Atesoglu E; Eren N; Gedük A; Mehtap O; Tarkun P; Hacıhanefioğlu A
Tumori; 2019 Dec; 105(6):NP24-NP27. PubMed ID: 30580656
[TBL] [Abstract][Full Text] [Related]
5. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
Baeksgaard L; Sørensen JB
Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
[TBL] [Abstract][Full Text] [Related]
6. Tumor lysis syndrome after bortezomib therapy for plasma cell leukemia.
Jaskiewicz AD; Herrington JD; Wong L
Pharmacotherapy; 2005 Dec; 25(12):1820-5. PubMed ID: 16305302
[TBL] [Abstract][Full Text] [Related]
7. An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome.
Mughal TI; Ejaz AA; Foringer JR; Coiffier B
Cancer Treat Rev; 2010 Apr; 36(2):164-76. PubMed ID: 20031331
[TBL] [Abstract][Full Text] [Related]
8. Bortezomib-induced tumor lysis syndrome in multiple myeloma.
Sezer O; Vesole DH; Singhal S; Richardson P; Stadtmauer E; Jakob C; Boral AL; Esseltine DL; Mehta J
Clin Lymphoma Myeloma; 2006 Nov; 7(3):233-5. PubMed ID: 17229340
[TBL] [Abstract][Full Text] [Related]
9. Tumour lysis syndrome: new therapeutic strategies and classification.
Cairo MS; Bishop M
Br J Haematol; 2004 Oct; 127(1):3-11. PubMed ID: 15384972
[TBL] [Abstract][Full Text] [Related]
10. Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature.
Hussain K; Mazza JJ; Clouse LH
Am J Hematol; 2003 Mar; 72(3):212-5. PubMed ID: 12605395
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review.
Coiffier B; Altman A; Pui CH; Younes A; Cairo MS
J Clin Oncol; 2008 Jun; 26(16):2767-78. PubMed ID: 18509186
[TBL] [Abstract][Full Text] [Related]
12. Tumour lysis syndrome in multiple myeloma after bortezomib (VELCADE) administration.
Terpos E; Politou M; Rahemtulla A
J Cancer Res Clin Oncol; 2004 Oct; 130(10):623-5. PubMed ID: 15449188
[TBL] [Abstract][Full Text] [Related]
13. Bortezomib administration is a risk factor associated with the development of tumor lysis syndrome in male patients with multiple myeloma: a retrospective study.
Kondo M; Hotta Y; Yamauchi K; Sanagawa A; Komatsu H; Iida S; Kimura K
BMC Cancer; 2020 Nov; 20(1):1117. PubMed ID: 33203424
[TBL] [Abstract][Full Text] [Related]
14. Tumor lysis syndrome associated with bortezomib: A post-hoc analysis after signal detection using the US Food and Drug Administration Adverse Event Reporting System.
Sanagawa A; Hotta Y; Kondo M; Nishikawa R; Tohkin M; Kimura K
Anticancer Drugs; 2020 Feb; 31(2):183-189. PubMed ID: 31789626
[TBL] [Abstract][Full Text] [Related]
15. High Risk of Tumor Lysis Syndrome in Symptomatic Patients with Multiple Myeloma with Renal Dysfunction Treated with Bortezomib.
Oiwa K; Morita M; Kishi S; Okura M; Tasaki T; Matsuda Y; Tai K; Hosono N; Ueda T; Yamauchi T
Anticancer Res; 2016 Dec; 36(12):6655-6662. PubMed ID: 27919998
[TBL] [Abstract][Full Text] [Related]
16. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus.
Cairo MS; Coiffier B; Reiter A; Younes A;
Br J Haematol; 2010 May; 149(4):578-86. PubMed ID: 20331465
[TBL] [Abstract][Full Text] [Related]
17. Emergency care: the tumor lysis syndrome.
Turtureanu-Hanganu E
Rev Med Chir Soc Med Nat Iasi; 2002; 106(4):705-11. PubMed ID: 14974215
[TBL] [Abstract][Full Text] [Related]
18. Tumor lysis syndrome at the beginning of thalidomide therapy for multiple myeloma.
Cany L; Fitoussi O; Boiron JM; Marit G
J Clin Oncol; 2002 Apr; 20(8):2212. PubMed ID: 11956286
[No Abstract] [Full Text] [Related]
19. Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model.
Montesinos P; Lorenzo I; Martín G; Sanz J; Pérez-Sirvent ML; Martínez D; Ortí G; Algarra L; Martínez J; Moscardó F; de la Rubia J; Jarque I; Sanz G; Sanz MA
Haematologica; 2008 Jan; 93(1):67-74. PubMed ID: 18166787
[TBL] [Abstract][Full Text] [Related]
20. Tumour lysis syndrome and acute renal failure in Burkitt's lymphoma. Description of 2 cases and a review of the literature on prevention and management.
Veenstra J; Krediet RT; Somers R; Arisz L
Neth J Med; 1994 Nov; 45(5):211-6. PubMed ID: 7830847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
